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OBJECTIVES: To evaluate the impact of pharmacists led intervention programme 
in order to evaluate knowledge, attitude and practice among Hepatitis B patients 
in Pakistan. METHODS: A non clinical randomized control trial was conducted 
whereby Hepatitis-B patients received an educational intervention through 
trained hospital pharmacists who provided them with information about 
Hepatitis-B. Knowledge, attitude and practice were measured by means of self-
administered questionnaire. Descriptive statistics were used to describe  
the demographic characteristics of the patients. Inferential statistics (Chi square 
test, and Mann-Whitney U test) were used for comparison between the groups. 
SPSS 17 was used for data analysis. RESULTS: Three hundred and ninety 
Hepatitis-B patients were randomly assigned to the study (195 patients in  
the control group and in the intervention group). No significant differences  
were observed in either group for mean age, gender, education, occupation, 
income and locality. A significant improvement (p<0.001) in the knowledge, 
attitude and practice (8.48±2.7, 3.87±1.2, 2.37±1.0 to 15.46±2.2, 5.05±1.0, 5.98±1.2) 
was observed in the interventional group. Significant difference (p<0.001) was 
observed after the completion of the intervention programme between the 
control group and in the intervention group. CONCLUSIONS: The pharmacist-led 
intervention caused a significant improvement in knowledge, attitude and 
practice scores of Hepatitis-B patients which will be helpful in the better disease 
management and control. It is recommended that the role of pharmacists in 
patient education must be acknowledged as an integral part of the health care 
system.  
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OBJECTIVES: In recent years, increasing efforts have been dedicated to assess 
the health-related quality of life (HRQL) in people infected with tuberculosis (TB). 
A variety of generic instruments exist to assess quality of life (QoL) in TB 
patients, but a psychometrically sound TB-specific HRQL instrument is lacking. 
The current study aimed to develop a self-reported HRQL measure specific for 
pulmonary TB patients in Iraq. METHODS: The core, general HRQL questionnaire 
is comprised of the Functional Assessment of Cancer Therapy-General (FACT-G) 
items. The FACT-G was selected because of its established psychometrics and 
history in measuring HRQL symptoms in patients with a variety of chronic 
illnesses. A modular approach was followed for the development of Functional 
Assessment of Chronic Illness Therapy-Tuberculosis (FACIT-TB) questionnaire in 
which a set of items assessing QoL issues not sufficiently covered by the core 
FACT-G items, but considered to be relevant to the target population, were 
added. The development process of an additional concerns subscale of the 
FACIT-TB instrument consisted of several stages, including: 1) Concept 
clarification; 2) Item pool generation; 3) Item reduction; 4) Refinement. RESULTS: 
In addition to the 27 items of the core questionnaire, a set of 20 items referring to 
disease symptoms related to the site of infection (Pulmonary TB); side effects 
and other issues related to treatment; and additional QoL dimensions such as 
fatigue, fear of disease transmission, and economic burden of the illness were 
included in the additional subscale of FACIT-TB. CONCLUSIONS: A rigorous 
method was applied in the development of FACIT-TB to fully understand the 
impact of the illness on QoL of TB patients. However, further linguistic validation 
and psychometric testing should be conducted to ensure conceptual 
equivalence, validity and reliability of the instrument and its relevance among 
Arabic-speaking patients in Iraq.  
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OBJECTIVES: The study evaluated the impact of a health educational 
intervention in improvement of health related quality of life (HRQoL) in Pakistani 
Hepatitis-B patients. METHODS: A non-clinical randomized control trial was 
conducted. Hepatitis B patients received an educational intervention through 
hospital pharmacists who provided them with information about Hepatitis-B 
treatment and management and improvement of HRQoL. Health Related Quality 
of Life was measured by Euroqol (EQ-5D). Descriptive statistics were used to 
describe the demographic characteristics of the patients. Inferential statistics 
(Chi square test, Mann-Whitney U test) were used for inter-group comparison. 
The intra- group comparison was performed by Wilcoxon Rank Sum test. SPSS 
17.0 was used for data analysis. RESULTS: Three hundred and ninety Hepatitis-B 
patients were randomly assigned to the study [195 in each group i.e. control 
group (CG) and the intervention group (IG)]. No significant differences were 
observed in either group for mean age, gender, education, occupation, income 
and locality. There was significant (p<0.001) increase in EQ-5D score from 
0.3498±0.3178 to 0.4739±0.2624 (in post interventional intervention group). The 
results revealed non-statistical significant (p=0.563) between the Interventional 
group (0.4726±0.2522) and control group (0.4745±0.2791) among overall HRQoL 
scores. CONCLUSIONS: The pharmacist-focused intervention led to a significant 
increase in the patient’s health related quality of life. Therefore, the role of 
pharmacists in patient education must be formalized and acknowledged as an 
official part of the health care system.  
INFECTION – Health Care Use & Policy Studies 
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OBJECTIVES: In 2009, voluntary public reporting of hospital health care 
personnel (HCP) vaccination rates began in Illinois. We describe our experience 
over 4 influenza seasons (2009-2013) and examine the impact universal policies 
have had on performance. METHODS: A secure website was used to report 
monthly HCP vaccination rates by each participating hospital. Overall and 
individual hospital performance was publicly reported each month. Statistical 
analysis was performed to compare the HCP vaccination rate before and after 
adoption of a universal policy to compare HCP vaccination rate by policy type for 
each month of the flu season. RESULTS: In the first two seasons, there were 11 
hospitals reporting with an average end of season rate of 76% (2009–2010) and 
81% (2010–2011). In the 2011–2012 season, there were 22 hospitals reporting, 9 of 
which had a new universal policy for HCP influenza vaccination. The average 
2011–2012 end of season rate was 72% for hospitals with a voluntary program 
and 95% for hospitals with a universal policy. HCP were also vaccinated earlier in 
the influenza season when a universal policy was in place, providing greater 
benefit over time. We found that there was a statistically significant difference in 
vaccination rate by type of policy at both the beginning of the influenza season 
and at the end of the influenza season. In the 2012-2013 season, there are 34 
hospitals voluntary participating which reflects a huge increase in terms of 
public reporting of HCP influenza vaccinations; updated results will be 
presented. CONCLUSIONS: A variety of factors may contribute to the rate of 
hospital HCP influenza vaccination. Public reporting of HCP influenza 
vaccination rates may contribute to implementation of universal employee 
vaccination policies. Hospitals with universal policies have higher vaccination 
rates than those with voluntary vaccination programs. Our study has 
demonstrated that implementation of a universal policy contributes to a 
dramatic increase in performance.  
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OBJECTIVES: Community-acquired pneumonia (CAP) is one of the leading causes 
of death due to infection and a primary indication for antibiotic therapy. Multiple 
guidelines exist for recommending initial antibiotic choice for treatment of CAP. 
This study was conducted to evaluate the trends in antibiotic choice for 
treatment of CAP in hospitalized patients (non-ICU) at a tertiary care center, 
Safdarjung Hospital, Delhi, India. METHODS: A retrospective medical record 
review of hospitalized adult patients discharged to home (mean hospital stay 
5.38 days (SD=2.97)) with a diagnosis of CAP in 2007 (n=139) and 2011 (n=142) was 
performed. A standardized form was completed by a trained medical resident. 
RESULTS: The pattern of antibiotic use in 2007 and 2011, respectively, was – 
monotherapy 30.2% versus 21.1%; combination of two antibiotics 61.1% versus 
65.5%; and combination of three antibiotics 8.6% versus 13.3%. 
Amoxicillin+clavulanic acid or ceftriaxone (β-lactam antibiotics) were most 
frequently used as monotherapy in both 2007 (80.9% and 9.5%) and 2011 (56.7% 
and 36.7%). In 2007, combinations of a β-lactam (amoxicillin+clavulanic acid or 
ceftriaxone) and fluoroquinolones (41.2%) or macrolides (31.8%) or 
aminoglycosides (10.6%) were prescribed. In 2011, combinations of 
fluoroquinolones (levofloxacin) and a β-lactam (43.0%) or combinations of β-
lactam and a macrolide (40.9%) were commonly given. Combination of three 
antibiotics usually included a β-lactam combined with macrolides or 
aminoglycosides or fluoroquinolones or metronidazole. Piperacillin+tazobactam 
or ceftazidime+tazobactam were prescribed to 12 patients in 2011 and none in 
2007. Third generation cephalosporins (ceftriaxone, ceftazidime, cefotaxime, 
cefixime) were given to 55 patients in 2011 versus 19 patients in 2007 (test of 
proportion p<0.01). CONCLUSIONS: The study indicates that third generation 
cephalosporins and piperacillin+tazobactam use at the study hospital is 
increasing, whereas amoxicillin+clavulanic acid use is decreasing in non-ICU 
hospitalized patients with CAP. This trend is not in accordance with published 
guidelines and especially concerning in light of emerging antimicrobial 
resistance.  
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OBJECTIVES: The study investigated the local retail drug market to determine 
the prices, availability and affordability of antimalarial medicines to generate 
information for improving access to ACTs METHODS: A cross-sectional survey 
was conducted in retail outlets in Enugu urban SE Nigeria in 2011, based on 
WHO/HAI recommendations. Nine medicines from seven categories of 
antimalarial drugs were surveyed in a sample of 38 retail outlets, selected 
randomly by type and location. Data was collected by structured interviews, in-
depth interviews, and retail audits from both private retail pharmacies and 
patent medicine vendors. RESULTS: The market was highly characterized by a 
wide range of antimalarial medicines, averaging 10 brands per outlet. SPs and 
 V A L U E  I N  H E A L T H  1 6  ( 2 0 1 3 )  A 1 - A 2 9 8  A97 
 
 
the ACTs were the most dominant categories accounting for over 70% of market 
volume. SPs were the cheaper and most popular agents particularly in PMVs 
while the ACTs were the most prescribed agents dominant in retail pharmacies. 
Prices of the drugs ranged from $0.13 to $8.17 per adult oral dose. ACTs were the 
most expensive antimalarials with a median price of $5.23 ($1.83 - $8.17) in a 
country where over 50% of the population lives below $2 a day, making them 
unaffordable for majority of the low-income population. CONCLUSIONS: The  
use of ACTs has become very significant, but still below the required policy level 
as the drugs of choice in malaria treatment, limited by high prices and 
inadequate information. Results confirm that in many countries access to ACTs 
is hindered by unaffordable prices for majority of the population in addition to 
limited information on their relative efficiency in malaria treatment. 
Procurement is the most determinant of high cost, making it the key policy 
target for price reduction for improved affordability. Hence the expected impact 
of the AmFm will certainly boost access to the ACTs and would significantly 
change study findings  
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OBJECTIVES: To estimate the coverage of the Expanded Programme on 
Immunization among children ≤5 years old in Colombia, to evaluate the 
opportunity of vaccination, and to identify factors associated with low coverage. 
METHODS: We conducted a cross-sectional survey in 80 municipalities of 
Colombia, with census block groups as primary sampling units, and blocks as 
secondary units. We identified all children in the targeted age group living in the 
sampled blocks, and asked their caregivers to provide children´s immunization 
record cards, when available. We also collected basic socio-demographic 
information. All procedures adhered to international guidelines on ethical 
conduct of research, and were approved by the IRB at the National University of 
Colombia, School of Medicine. RESULTS: Estimated coverage was good for 
vaccines scheduled during the first 15 months of life: BCG 93.2% (95%CI: 92–94.4), 
DTP/Hib/HepB 89.6% (87.8–91.5), MMR 92.5% (90.8–94.2), yellow fever 89.5% (87.1–
91.8); but was lower among older children: DTP first booster dose 85.1% (83.4–
86.7), second booster dose 63.7% (57.3–70.2); MMR booster dose 52.9% (46.4–59.4). 
Opportunity of vaccination showed poorer results: for instance, timely 
administration of DTP/Hib/HepB occurred in only 44.2% of the children evaluated 
(41.4–47.1), and MMR in 71.2% (68.9–73.4). Higher socioeconomic status, time 
living in the municipality, mother´s years of school completed, and affiliation to 
social security were associated with better vaccine coverage (p<0.001); children 
of internally displaced families, children pertaining to a minority, and those 
coming from families with greater number of siblings had lower coverage. 
CONCLUSIONS: Vaccination coverage in children <15 months meets the WHO 
goal of 90%, or is very close to it, though coverage in older children falls below 
that goal. Delayed immunization is a common problem in Colombia, which may 
result in reduced protection. There are few modifiable factors associated with 
low coverage, though the identification of vulnerable populations may help to 
improve the reach of immunization programs.  
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OBJECTIVES: Investigate rational use of prescription drugs in Ministry of Health 
(MOH) in Saudi Arabia, using WHO level II indicators, and whether these 
measures are related to Pharmacy and Therapeutics Committee (P&TC) 
development level. METHODS: The study used retrospective data collected 
during 2003 from cross-sectional survey and prescriptions audit of 19 different 
outpatient settings of MOH hospitals in rural and urban areas; because of the 
scope of the study, we tested only 1 out of 12 indicators of WHO core drug use 
level II indicators (WHO/DAP/93.1); namely; the number of encounters with 
antibiotic prescribed. Binary logistic regression technique was used to test the 
likelihood of antibiotics prescribing across hospital and patient characteristics. 
RESULTS: Of 2850 patients, the average number of drugs prescribed per 
encounter was 2.41 higher than recommended target of WHO (<2); In hospitals 
serving urban areas, the antibiotics prescribing rates were 21.5% and 37.5% of 
total encounters in urban and rural hospitals respectively (WHO recommended 
target (<30%)). Antibiotics utilization was significantly higher in rural areas and 
in hospitals with undeveloped P&TC. The likelihood of antibiotics prescribing 
was 1.298 in hospitals with undeveloped P&TC compared to developed P&TC, 
2.550 for rural compared to urban areas, 1.390 for male patients, 4.462 for patient 
from (≤1)year, 5.412 for patients (2-4) years, 4.015 for patients (5-14)years, 1.439 
for patients (15-44)years. CONCLUSIONS: The data demonstrated that irrational 
use of medicines might exist in MOH hospitals, antibiotics overutilization in 
rural hospitals is an indication of it. The irrational prescribing might be 
associated with geographic areas, particularly, at hospitals serving rural areas. 
Furthermore, lack of effective P&TC might contribute to irrational prescribing in 
hospitals serving both urban and rural areas. Adoption of effective formulary 
system is recommended including adopting effective P&TC and strict guidelines 
and monitoring of antibiotic use to mitigate the risk of antibiotics resistance.  
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OBJECTIVES: The potential for neuropsychiatric side effects may be a treatment 
barrier for hepatitis C virus (HCV) patients with psychiatric comorbidities. This 
study’s primary objective was to compare medication treatment rates among 
HCV patients with and without psychiatric comorbidities. A secondary objective 
was assessing the impact of selection criteria on results. METHODS: Adult 
Medicaid beneficiaries with HCV (ICD-9-CM 070.44, 070.54) from July 1, 2009 
through June 30, 2011 and no interferon alfa (INF-a) treatment 6 months prior 
were identified using Truven Health MarketScan® Treatment Pathways. Patients 
without 6 months pre/post enrollment and a confirmatory HCV diagnosis were 
excluded. Post-index treatment rates given pre-index psychiatric comorbidity 
were calculated. Sensitivity analyses were performed, dropping the confirmatory 
diagnosis requirement and using a broader HCV diagnosis list (070.41, 070.44, 
070.51, 070.54, 070.7x). RESULTS: Psychiatric comorbidities measured in the 
sample (n=5,083) were alcohol abuse (16.6%), anxiety (20.3%), mood disorders 
(38.0%), schizophrenia (8.0%), and substance abuse (21.1%). Overall, 13.8% were 
treated with conventional or pegylated INF-a, most along with ribavirin. Protease 
inhibitor utilization (approved for HCV in 2011) was <1%. Alcohol abuse was 
associated with lower INF-a treatment rates (9.5% vs. 14.6%, p<0.001). Anxiety 
(15.9% vs. 13.2%, p=0.025) and mood disorder (15.1% vs. 13.0%, p=0.038) patients 
had higher rates, compared to patients without these comorbidities. Alcohol 
abuse and anxiety trends were similar after dropping the confirmatory diagnosis 
requirement (n= 10,335), but mood disorder was no longer significant. Using the 
broader diagnosis list (n=9,004), alcohol abuse (5.4% vs. 8.1%, p<0.001), 
schizophrenia (5.5% vs. 7.9%, p=0.017), and substance abuse (6.3% vs. 8.1%, 
p=0.009) were associated with lower treatment rates; anxiety and mood disorder 
had no significant effect. CONCLUSIONS: Psychiatric comorbidities were 
prevalent among HCV patients. Some comorbidities were associated with 
increased INF-a treatment rates, contrary to expectations. Minor sample 
selection changes impacted results, suggesting a need to carefully consider 
inclusion/exclusion criteria.  
 
PIN97  
COMORBID RISK AND CORRELATES OF PNEUMOCOCCAL VACCINATION 
AMONG LATENT CLASSES OF OLDER ADULTS IN THE CROSS-SECTIONAL 
NATIONAL HEALTH AND WELLNESS SURVEY IN BRAZIL  
Goren A1, Roberts CS2, Victor T3 
1Kantar Health, New York, NY, USA, 2Pfizer, New York, NY, USA, 3Kantar Health, Princeton, NJ, 
USA  
OBJECTIVES: To investigate predictors of pneumococcal polysaccharide vaccine 
(PPV) use across latent classes of older Brazilian adults, to understand 
characteristics associated with use in subpopulations with varying 
characteristics. METHODS: Data from the patient-reported, Internet-based 2011 
National Health and Wellness Survey in Brazil (n=12,000 adults) were used. 
Mixture modeling was applied to identify latent classes among respondents aged 
≥50 based on sociodemographics, health attitudes and behaviors, and health care 
resource use. Logistic regressions predicted PPV use (ever vs. never) within 
classes, from covariates including moderate-risk comorbidities (chronic disease, 
immunocompetent), high risk status (immunocompromised), flu vaccination in 
past year, and parent/caregiver of a child receiving pneumococcal vaccination. 
RESULTS: Among 3,195 respondents ≥50, two latent classes emerged. Class 1 
(assigned n=1,981) versus 2 (n=1,214) respondents had higher adjusted odds of 
being educated beyond high school (OR=26.75), partnered (OR=2.29), insured 
(OR=2.08), male (OR=1.80), exercising (OR=1.09), overweight/obese (OR≥1.18), and 
wealthier (OR≥1.81), all p<0.001; they were also younger (Mean=56.2 vs. 72.5 
years, respectively), visited traditional providers and the emergency room more 
frequently, and had higher physician-contact and lower prescription-avoidant 
attitudes, all p<0.05. Class 1 (9.9%) versus 2 (6.9%) PPV use was higher, as were 
rates of heart and lung disease, smoking, and child vaccination, while flu 
vaccination was lower, all p<0.05. In Class 1, child pneumococcal vaccination 
(OR=6.82), flu vaccination (OR=2.49), and chronic heart disease (OR=1.60) 
predicted PPV use, all p≤0.015. In Class 2, only child vaccination (OR=5.61) was 
significant, p=0.029. CONCLUSIONS: In Brazil, child vaccination may be a 
population-wide predictor of adult PPV uptake. Among younger, more affluent 
respondents with better health care access and attitudes, higher PPV use was 
associated with flu vaccination and heart disease. Among remaining elderly 
respondents, PPV uptake was lower and not significantly associated with risk 
factors, suggesting the need for better risk-based access.  
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OBJECTIVES: Improving and reducing disparities in time to HAART initiation and 
virologic suppression (VS) can assist in reducing U.S. human immunodeficiency 
virus (HIV) incidence. METHODS: Using data from ARV-naïve patients who 
enrolled in HOPS in 2000-2010 ≤6 months of HIV diagnosis and attended ≥2 visits, 
we assessed temporal trends and correlates of initiating HAART and achieving 
VS (<500 copies/mL) via Kaplan-Meier curves and Cox proportional hazards 
models. RESULTS: Among 1,112 patients included in our analysis, patients were 
less likely to start HAART and achieve VS ≤1 year of diagnosis if they were 
